Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

Cytochrome P450 inhibitor

DRUG CLASS:

Cytochrome P450 inhibitor

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (0)

posaconazole (0)

elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (0)

posaconazole (0)

›

BRAF mutation	Melanoma	BRAF mutation	Melanoma	FORE-8394 + cobicistat Sensitive: C3 – Early Trials FORE-8394 + cobicistat Sensitive : C3	FORE-8394 + cobicistat Sensitive: C3 – Early Trials FORE-8394 + cobicistat Sensitive : C3
BRAF mutation	Colorectal Cancer	BRAF mutation	Colorectal Cancer	FORE-8394 + cobicistat Sensitive: C3 – Early Trials FORE-8394 + cobicistat Sensitive : C3	FORE-8394 + cobicistat Sensitive: C3 – Early Trials FORE-8394 + cobicistat Sensitive : C3
BRAF mutation	Thyroid Gland Anaplastic Carcinoma	BRAF mutation	Thyroid Gland Anaplastic Carcinoma	FORE-8394 + cobicistat Sensitive: C3 – Early Trials FORE-8394 + cobicistat Sensitive : C3	FORE-8394 + cobicistat Sensitive: C3 – Early Trials FORE-8394 + cobicistat Sensitive : C3
BRAF mutation	Thyroid Gland Papillary Carcinoma	BRAF mutation	Thyroid Gland Papillary Carcinoma	FORE-8394 + cobicistat Sensitive: C3 – Early Trials FORE-8394 + cobicistat Sensitive : C3	FORE-8394 + cobicistat Sensitive: C3 – Early Trials FORE-8394 + cobicistat Sensitive : C3
BRAF mutation	Glioma	BRAF mutation	Glioma	FORE-8394 + cobicistat Sensitive: C3 – Early Trials FORE-8394 + cobicistat Sensitive : C3	FORE-8394 + cobicistat Sensitive: C3 – Early Trials FORE-8394 + cobicistat Sensitive : C3